$IRTC

Patterson Chad sold $331K of IRTC

Patterson Chad (CHIEF COMM & PRODUCT OFFICER) sold 2,712 shares of iRhythm Holdings, Inc. (IRTC) at $122.12 ($0.33M total) on 2026-08-03.

Original reporting
SEC EDGAR · Patterson Chad
Published Aug 4, 2026, 8:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 8:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IRTC
Neutral
medium confidence
Mentioned
$IRTC
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IRTCNeutralLow
01

Why it matters

This provides a fresh datapoint on insider behavior but does not introduce new fundamentals, guidance, or legal/regulatory developments.

02

Market read

Traders may monitor insider selling as a sentiment input, but the filing alone is unlikely to drive a durable repricing without accompanying fundamental news.

03

What to watch

The article does not state whether the sale was part of compensation, tax withholding, or other pre-planned arrangements; also, insider sales can be scheduled around personal needs rather than company outlook.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-04, sale dated 2026-08-03

Background

The article is a Form 4 insider transaction disclosure for iRhythm Holdings, Inc.

Company-level read

Ticker impact

$IRTCNeutralMedium confidence
Context

iRhythm Holdings insider Patterson Chad sold 2,712 shares at $122.1209 on 2026-08-03, totaling $331,191.88.

Expected impact

Likely limited near-term impact; any effect would be small and sentiment-driven.

Evidence & confidence

Form 4 shows an officer sale, but the filing provides no new business information, guidance, or regulatory/legal development. Absence of a 10b5-1 plan can raise interpretive noise, yet insider sales are often non-informational.

Market effects

Minimal; this is company-specific insider activity with no sector-wide signal in the text.

None indicated.

None indicated.

Counterpoint

The sale may be purely liquidity or tax-related, especially since the filing does not indicate any operational or financial deterioration.

Key entities

  • iRhythm Holdings, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Patterson Chad

    Chief Commercial and Product Officer who sold shares.

Related articles

$IRTCMedAI 8/10

Why iRhythm (IRTC) Stock Is Trading Up Today

iRhythm Technologies (IRTC) shares rose about 2% after the company reported Q2 results that beat expectations and lifted full-year revenue guidance. Revenue was $224.2 million, up 20.1% year over year. EPS was $0.58 versus $0.00 consensus. Full-year revenue guidance was raised to $885 million at the midpoint.

$IRTCHigh

iRhythm Holdings, Inc. (IRTC): Results of Operations and Financial Condition

iRhythm Holdings, Inc. (IRTC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 irtcq22026ex991pressrelease.htm EX-99.1 Document Exhibit 99.1 iRhythm Holdings Announces Second Quarter 2026 Financial Results SAN FRANCISCO, August 6, 2026 -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solut

$IRTCMedAI 8/10

iRhythm Investigates Cyber Incident After Hackers Claim Access To Sensitive Data - iRhythm Holdings (NASD

iRhythm Holdings said in an SEC filing that it launched its cybersecurity response after detecting suspicious activity and hired external advisors to investigate a claimed hack. The threat actor alleged access to proprietary data and patient-protected health and personal information and demanded payment. iRhythm confirmed some data was exfiltrated from third-party-hosted apps and deemed the incident material as of June 10, 2026, while saying core operations and patient safety were unaffected.